| 1.588 -1.046 (-39.71%) 09-14 16:04 |
|
| Open: | 1.762 |
| High: | 1.790 |
| Low: | 1.588 |
| Pre. close: | 2.634 |
| Volume: | 281,328 |
| Avg. volume: | 145,922 |
| MA (50): | 2.658 |
| MA (200): | 3.149 |
| Year high: | 4.840 |
| Year low: | 1.588 |
| Market cap: | 115(M) |
| EPS: | -0.571 |
| PE ratio: | -2.78 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Mon, 14 Sep 2026
Nasdaq Down Over 200 Points; Cellectis Shares Plunge - Benzinga
Mon, 14 Sep 2026
What's Going On With Cellectis Stock Monday? - Cellectis (NASDAQ:CLLS) - Benzinga
Mon, 14 Sep 2026
CLLS Looks 5.4% Overvalued on GF Value™ Amid Unprofitability Con - GuruFocus
Mon, 14 Sep 2026
ALCLS: Pivoting to in vivo gene editing with two lead assets, aiming for first clinical data in 2027 - TradingView
Mon, 14 Sep 2026
Cellectis (CLLS) winds down CAR-T to fund in-body gene editing push and a longer cash runway - Stock Titan
Mon, 14 Sep 2026
A shift to gene editing will move Cellectis away from developing two cell therapies. - Stock Titan
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.